NCT04570722 Ipsilateral Peripheral Intravenous Access Procedures (The iPIVAP Study) Status COMPLETED Phase NA
NCT04569955 Knowledge and Perception of Clinical Trial Participation in Breast Cancer Patients in Egypt Status UNKNOWN Phase N/A
NCT04569747 A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04568941 Comparison Study of Different Tumor Biopsy Method for Sentinel Lymph Node Biopsy in Breast Cancer Status UNKNOWN Phase NA
NCT04568616 Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04568161 Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses Status COMPLETED Phase NA
NCT04567420 DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE) Status RECRUITING Phase PHASE2
NCT04563013 Study of the Effects of Transcutaneous Vagus Nerve Stimulation on Cancer Patients Status COMPLETED Phase NA
NCT04561297 Assessing the Utility of Tissue Dielectric Constant (TDC) Measurements to Differentiate Breast Cancer From Healthy Breasts Status COMPLETED Phase NA
NCT04559854 Mindful After Cancer: A Mindfulness-based Therapy Intervention for Sexual Health After Cancer Status COMPLETED Phase NA
NCT04554927 Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT04553133 PF-07104091 as a Single Agent and in Combination Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04549207 Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE4